Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 326986
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Prostate Specific Antigen (PSA) Blood Based Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Prostate Specific Antigen (PSA) Blood Based Biomarker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Diagnostics accounting for % of the Prostate Specific Antigen (PSA) Blood Based Biomarker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Screening Biomarker segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Prostate Specific Antigen (PSA) Blood Based Biomarker include ProteoMediX, Cleveland Diagnostics, Randox, Roche, and GENFIT, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Prostate Specific Antigen (PSA) Blood Based Biomarker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Screening Biomarker

Diagnosis Biomarker

Market segment by Application, can be divided into

Diagnostics

Drug Discovery

Personalized Medicine

Others

Market segment by players, this report covers

ProteoMediX

Cleveland Diagnostics

Randox

Roche

GENFIT

Nutech Cancer Biomarkers

OGT (Sysmex Group)

Minomic

Creative Diagnostics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Prostate Specific Antigen (PSA) Blood Based Biomarker product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Prostate Specific Antigen (PSA) Blood Based Biomarker, with revenue, gross margin and global market share of Prostate Specific Antigen (PSA) Blood Based Biomarker from 2019 to 2022.

Chapter 3, the Prostate Specific Antigen (PSA) Blood Based Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Specific Antigen (PSA) Blood Based Biomarker market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Prostate Specific Antigen (PSA) Blood Based Biomarker research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Blood Based Biomarker

1.2 Classification of Prostate Specific Antigen (PSA) Blood Based Biomarker by Type

1.2.1 Overview: Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type in 2021

1.2.3 Screening Biomarker

1.2.4 Diagnosis Biomarker

1.3 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Application

1.3.1 Overview: Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size & Forecast

1.5 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast by Region

1.5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region, (2017-2022)

1.5.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Prospect (2017-2028)

1.5.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Prospect (2017-2028)

1.5.6 South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers

1.6.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

1.6.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Trends Analysis

2 Company Profiles

2.1 ProteoMediX

2.1.1 ProteoMediX Details

2.1.2 ProteoMediX Major Business

2.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.1.4 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 ProteoMediX Recent Developments and Future Plans

2.2 Cleveland Diagnostics

2.2.1 Cleveland Diagnostics Details

2.2.2 Cleveland Diagnostics Major Business

2.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.2.4 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Cleveland Diagnostics Recent Developments and Future Plans

2.3 Randox

2.3.1 Randox Details

2.3.2 Randox Major Business

2.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.3.4 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Randox Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.4.4 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Roche Recent Developments and Future Plans

2.5 GENFIT

2.5.1 GENFIT Details

2.5.2 GENFIT Major Business

2.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.5.4 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 GENFIT Recent Developments and Future Plans

2.6 Nutech Cancer Biomarkers

2.6.1 Nutech Cancer Biomarkers Details

2.6.2 Nutech Cancer Biomarkers Major Business

2.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.6.4 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Nutech Cancer Biomarkers Recent Developments and Future Plans

2.7 OGT (Sysmex Group)

2.7.1 OGT (Sysmex Group) Details

2.7.2 OGT (Sysmex Group) Major Business

2.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.7.4 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 OGT (Sysmex Group) Recent Developments and Future Plans

2.8 Minomic

2.8.1 Minomic Details

2.8.2 Minomic Major Business

2.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.8.4 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Minomic Recent Developments and Future Plans

2.9 Creative Diagnostics

2.9.1 Creative Diagnostics Details

2.9.2 Creative Diagnostics Major Business

2.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

2.9.4 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Creative Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Prostate Specific Antigen (PSA) Blood Based Biomarker Players Market Share in 2021

3.2.2 Top 10 Prostate Specific Antigen (PSA) Blood Based Biomarker Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Players Head Office, Products and Services Provided

3.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Mergers & Acquisitions

3.5 Prostate Specific Antigen (PSA) Blood Based Biomarker New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Market Share by Type (2017-2022)

4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application (2017-2022)

5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2028)

6.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2028)

6.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

6.3.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2028)

6.3.2 United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

6.3.3 Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

6.3.4 Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2028)

7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2028)

7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

7.3.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2028)

7.3.2 Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

7.3.3 France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

7.3.5 Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

7.3.6 Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2028)

8.2 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2028)

8.3 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region

8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Region (2017-2028)

8.3.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8.3.3 Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8.3.4 South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8.3.5 India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

8.3.7 Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2028)

9.2 South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2028)

9.3 South America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

9.3.1 South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2028)

9.3.2 Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

9.3.3 Argentina Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2028)

10.2 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2028)

10.3 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2028)

10.3.2 Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

10.3.4 UAE Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) by Region (2017-2022)

Table 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Region (2023-2028)

Table 6. ProteoMediX Corporate Information, Head Office, and Major Competitors

Table 7. ProteoMediX Major Business

Table 8. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 9. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Cleveland Diagnostics Corporate Information, Head Office, and Major Competitors

Table 11. Cleveland Diagnostics Major Business

Table 12. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 13. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Randox Corporate Information, Head Office, and Major Competitors

Table 15. Randox Major Business

Table 16. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 17. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 21. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. GENFIT Corporate Information, Head Office, and Major Competitors

Table 23. GENFIT Major Business

Table 24. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 25. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Nutech Cancer Biomarkers Corporate Information, Head Office, and Major Competitors

Table 27. Nutech Cancer Biomarkers Major Business

Table 28. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 29. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. OGT (Sysmex Group) Corporate Information, Head Office, and Major Competitors

Table 31. OGT (Sysmex Group) Major Business

Table 32. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 33. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Minomic Corporate Information, Head Office, and Major Competitors

Table 35. Minomic Major Business

Table 36. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 37. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Creative Diagnostics Corporate Information, Head Office, and Major Competitors

Table 39. Creative Diagnostics Major Business

Table 40. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product and Solutions

Table 41. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 43. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 44. Breakdown of Prostate Specific Antigen (PSA) Blood Based Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Prostate Specific Antigen (PSA) Blood Based Biomarker Players Head Office, Products and Services Provided

Table 46. Prostate Specific Antigen (PSA) Blood Based Biomarker Mergers & Acquisitions in the Past Five Years

Table 47. Prostate Specific Antigen (PSA) Blood Based Biomarker New Entrants and Expansion Plans

Table 48. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) by Type (2017-2022)

Table 49. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Type (2017-2022)

Table 50. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Forecast by Type (2023-2028)

Table 51. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022)

Table 52. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Forecast by Application (2023-2028)

Table 53. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 54. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 55. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 56. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 57. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 58. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 59. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 60. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 61. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 62. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 63. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 64. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 65. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 66. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 67. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 68. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 69. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Region (2017-2022) & (USD Million)

Table 70. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Region (2023-2028) & (USD Million)

Table 71. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 72. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 73. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 74. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 75. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 76. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2023-2028) & (USD Million)

Table 77. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2017-2022) & (USD Million)

Table 78. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Type (2023-2028) & (USD Million)

Table 79. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2017-2022) & (USD Million)

Table 80. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Application (2023-2028) & (USD Million)

Table 81. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2017-2022) & (USD Million)

Table 82. Middle East & Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Prostate Specific Antigen (PSA) Blood Based Biomarker Picture

Figure 2. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type in 2021

Figure 3. Screening Biomarker

Figure 4. Diagnosis Biomarker

Figure 5. Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Application in 2021

Figure 6. Diagnostics Picture

Figure 7. Drug Discovery Picture

Figure 8. Personalized Medicine Picture

Figure 9. Others Picture

Figure 10. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Region (2017-2028)

Figure 13. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Region in 2021

Figure 14. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers

Figure 20. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

Figure 21. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends

Figure 22. ProteoMediX Recent Developments and Future Plans

Figure 23. Cleveland Diagnostics Recent Developments and Future Plans

Figure 24. Randox Recent Developments and Future Plans

Figure 25. Roche Recent Developments and Future Plans

Figure 26. GENFIT Recent Developments and Future Plans

Figure 27. Nutech Cancer Biomarkers Recent Developments and Future Plans

Figure 28. OGT (Sysmex Group) Recent Developments and Future Plans

Figure 29. Minomic Recent Developments and Future Plans

Figure 30. Creative Diagnostics Recent Developments and Future Plans

Figure 31. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Players in 2021

Figure 32. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 33. Global Top 3 Players Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share in 2021

Figure 34. Global Top 10 Players Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share in 2021

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 36. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Type in 2021

Figure 37. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share Forecast by Type (2023-2028)

Figure 38. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Application in 2021

Figure 39. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share Forecast by Application (2023-2028)

Figure 40. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Type (2017-2028)

Figure 41. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Application (2017-2028)

Figure 42. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Country (2017-2028)

Figure 43. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Type (2017-2028)

Figure 47. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Application (2017-2028)

Figure 48. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Country (2017-2028)

Figure 49. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. France Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. United Kingdom Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Type (2017-2028)

Figure 55. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Application (2017-2028)

Figure 56. Asia-Pacific Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Region (2017-2028)

Figure 57. China Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. India Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Type (2017-2028)

Figure 64. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Application (2017-2028)

Figure 65. South America Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Country (2017-2028)

Figure 66. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Type (2017-2028)

Figure 69. Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Market Share by Application (2017-2028)

Figure 70. Middle East and Africa Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Country (2017-2028)

Figure 71. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. UAE Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz